Skip to content
MarketScale
‹ Back to IndustriesHealthcare

CurveBeam Connect: An Insider Look at the New CurveBeam Cloud Technology

Despite all of the challenges that the COVID-19 pandemic has brought us over the past year, it’s also shown us a silver lining: When it comes to the systems in our society, there’s so much that we can still improve on. Take the medical field, for example. So many of us have waited weeks or…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
CurveBeam Connect: An Insider Look at the New CurveBeam Cloud Technology

Despite all of the challenges that the COVID-19 pandemic has brought us over the past year, it’s also shown us a silver lining: When it comes to the systems in our society, there’s so much that we can still improve on.

Take the medical field, for example. So many of us have waited weeks or months to get a medical procedure done, shuttling back and forth between labs and doctors’ offices, sometimes even for the smallest things.

However, a new development from CurveBeam is set to change all that.

On this episode of the CurveBeam Connect podcast, host and CurveBeam Marketing Director Vinti Singh met up with Turner Dean and Stuti Singh to talk about CurveBeam Cloud, the newest offering in the company’s suite of products. Dean, CurveBeam’s Vice President of Sales, and Singh, Senior Systems Engineer, have worked tirelessly to develop this product and have much to share about their latest development.

“We saw the opportunity to create an ecosystem where we could collaborate and solve a number of issues that our clients have had over the years in terms of managing their data sets and their information,” Dean said.

With the implementation of this new, cloud-based platform, “we see opportunity to eliminate time, expense, mistakes and errors, and make the process a lot more efficient and cost-effective,” he continued.

For the latest news and diagnostic imaging thought leadership from CurveBeam, as well as updates when the CurveBeam Cloud platform launches, visit our website at curvebeam.com.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512